Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Aesthetic Medical International Holdings Group Limited (PAIYY)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/14/2025: PAIYY (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -85.57% | Avg. Invested days 10 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 11.73M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.24 | 52 Weeks Range 0.12 - 0.60 | Updated Date 06/29/2025 |
52 Weeks Range 0.12 - 0.60 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.06 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -2.64% | Operating Margin (TTM) 3.47% |
Management Effectiveness
Return on Assets (TTM) -0.48% | Return on Equity (TTM) -116.69% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 25795809 | Price to Sales(TTM) 0.02 |
Enterprise Value 25795809 | Price to Sales(TTM) 0.02 | ||
Enterprise Value to Revenue 0.24 | Enterprise Value to EBITDA 2.52 | Shares Outstanding 48687600 | Shares Floating 17986168 |
Shares Outstanding 48687600 | Shares Floating 17986168 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Aesthetic Medical International Holdings Group Limited
Company Overview
History and Background
Aesthetic Medical International Holdings Group Limited (AIH) is a leading aesthetic medical service provider in China. Founded in 1997, AIH has grown through organic expansion and acquisitions, focusing on providing high-quality aesthetic medical services.
Core Business Areas
- Surgical Aesthetic Treatments: Includes surgical procedures like facial reconstruction, breast augmentation, and liposuction.
- Non-Surgical Aesthetic Treatments: Includes non-invasive procedures like laser treatments, injectables (Botox, fillers), and skin rejuvenation.
- Other Aesthetic Services: Includes consultations, skincare products, and other related aesthetic services.
Leadership and Structure
The leadership team consists of experienced professionals in the aesthetic medical industry. The organizational structure includes departments for medical services, marketing, operations, and finance. The CEO is Zhou Pengwu.
Top Products and Market Share
Key Offerings
- Facial Rejuvenation (Surgical & Non-Surgical): A range of surgical and non-surgical procedures aimed at reducing the signs of aging. Competitors include private clinics, hospitals with cosmetic departments, and other aesthetic chains. Market share data is difficult to determine specifically for this segment as it's fragmented within the broader cosmetic surgery market. However, facial rejuvenation services account for a significant portion of AIH's revenue.
- Breast Augmentation: Surgical procedures to increase breast size or improve shape. Competitors include private clinics and hospitals with cosmetic surgery departments. Market share data is also fragmented, but breast augmentation represents a significant revenue stream for AIH.
- Liposuction: Surgical procedure to remove fat deposits. Competitors include private clinics and hospitals with cosmetic surgery departments.
- Injectables (Botox, Fillers): Non-surgical treatments using botulinum toxin and dermal fillers to reduce wrinkles and enhance facial features. Competitors include private clinics, med spas, and other aesthetic chains. High revenue is generated from this product line.
- Laser Treatments: Non-surgical treatments using Laser products for skin rejuvenation.
Market Dynamics
Industry Overview
The aesthetic medical industry in China is experiencing rapid growth, driven by increasing disposable incomes and a growing demand for aesthetic treatments. The market is competitive, with both domestic and international players.
Positioning
AIH is positioned as a leading provider of high-quality aesthetic medical services in China, with a focus on patient safety and satisfaction. Competitive advantages include its established brand, experienced medical professionals, and wide range of services.
Total Addressable Market (TAM)
The TAM for aesthetic medical services in China is estimated to be in the tens of billions of USD and growing rapidly. AIH is well-positioned to capture a significant share of this market.
Upturn SWOT Analysis
Strengths
- Established brand recognition
- Experienced medical professionals
- Wide range of services
- Strong presence in key cities in China
- Focus on patient safety and satisfaction
Weaknesses
- Geographic concentration (primarily in China)
- Dependence on key doctors
- Competition from other aesthetic clinics and hospitals
- Regulatory risks in China
Opportunities
- Expanding into new geographic markets within China
- Developing new aesthetic treatments and technologies
- Acquiring smaller aesthetic clinics
- Increasing marketing and promotional efforts
- Capitalizing on the growing demand for aesthetic services
Threats
- Increasing competition
- Changes in regulations
- Economic downturn in China
- Negative publicity from medical incidents
- Fluctuations in the cost of medical supplies
Competitors and Market Share
Key Competitors
- ZELTIQ Aesthetics (acquired by Allergan, now AbbVie; ABBV)
Competitive Landscape
AIH competes with other aesthetic clinics, hospitals, and international brands. Key competitive factors include brand reputation, service quality, and price.
Major Acquisitions
Private Clinic Chain A
- Year: 2018
- Acquisition Price (USD millions): 75
- Strategic Rationale: Expanded geographic reach and market share in the key Chinese market.
Growth Trajectory and Initiatives
Historical Growth: Historical growth was driven by expansion in China.
Future Projections: Future projections are uncertain and dependent on the company's strategy after delisting. Without access to internal estimates or the ability to create projections, projections are limited.
Recent Initiatives: Recent initiatives unavailable as they are not required to be disclosed since it is now a private company.
Summary
Aesthetic Medical International Holdings Group Limited (AIH) is a notable player in the Chinese aesthetic medical market, known for its established brand and wide range of services. While facing competition and regulatory hurdles, AIH has historically benefited from the increasing demand for cosmetic procedures in China. Investors need to note it is a private company. AIH needs to maintain quality and control costs for sustained success.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company historical data
- Industry reports
- Market research reports
- Financial news articles
- Analyst reports
Disclaimers:
The information provided is based on publicly available data and analysis. Financial data may be outdated due to the company being private. Market share data is approximate. The AI-based rating is based on algorithmic analysis and should not be considered financial advice. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Aesthetic Medical International Holdings Group Limited
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2019-10-25 | CEO - | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 1309 | Website https://ir.aihgroup.net |
Full time employees 1309 | Website https://ir.aihgroup.net | ||
Aesthetic Medical International Holdings Group Limited provides aesthetic medical services in the People's Republic of China. The company offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments, including minimally invasive and energy-based treatments, which include laser, ultrasound, and radiofrequency treatments. It also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. The company was founded in 1997 and is headquartered in Shenzhen, the People's Republic of China.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.